The E. coli CNF1 as a pioneering therapy for the central nervous system diseases

Toxins (Basel). 2014 Jan 7;6(1):270-82. doi: 10.3390/toxins6010270.

Abstract

The Cytotoxic Necrotizing Factor 1 (CNF1), a protein toxin from pathogenic E. coli, modulates the Rho GTPases, thus, directing the organization of the actin cytoskeleton. In the nervous system, the Rho GTPases play a key role in several processes, controlling the morphogenesis of dendritic spines and synaptic plasticity in brain tissues. This review is focused on the peculiar property of CNF1 to enhance brain plasticity in in vivo animal models of central nervous system (CNS) diseases, and on its possible application in therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Bacterial Toxins / pharmacology*
  • Central Nervous System Diseases / therapy*
  • Disease Models, Animal
  • Escherichia coli
  • Escherichia coli Proteins / pharmacology*
  • Genetic Therapy
  • Humans
  • Neurons / cytology
  • Neurons / metabolism
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism

Substances

  • Bacterial Toxins
  • Escherichia coli Proteins
  • cytotoxic necrotizing factor type 1
  • rho GTP-Binding Proteins